These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2023487)

  • 1. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exploration of the route of complement activation in idiopathic membranoproliferative glomerulonephritis and lupic nephropathy].
    Gutiérrez Millet V; Prieto C; Ortuño MT; Usera G; Jarillo MD; Ruilope LM; Rodicio JL
    Rev Clin Esp; 1978 Nov; 151(3):223-8. PubMed ID: 740997
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complement activation at low temperature. I. The profile of complement component of patients' sera].
    Yukiyama Y; Yoshida K; Hirose S
    Arerugi; 1984 May; 33(5):275-81. PubMed ID: 6477140
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement deficiencies in humans and animals: links to autoimmunity.
    Lewis MJ; Botto M
    Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The complement system and clinical effects of its disorders].
    Siegert CE; van Es LA; Daha MR
    Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2268-73. PubMed ID: 8984378
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 9. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complement deficiency, immunocomplexes and lupus erythematosus].
    Vivanco Martínez F
    Rev Clin Esp; 1987 Mar; 180(5):264-8. PubMed ID: 3602524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in clinical methods of complement system analysis and data interpretation].
    Inai S
    Nihon Rinsho; 1988 Sep; 46(9):2046-53. PubMed ID: 3149350
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
    Jin A
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV; Selivanova IA; Poroshina NS; Gagarina LN
    Vopr Revm; 1973; 13(2):51-2. PubMed ID: 4772875
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement and its breakdown products in SLE.
    Sturfelt G; Truedsson L
    Rheumatology (Oxford); 2005 Oct; 44(10):1227-32. PubMed ID: 15972354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of hemolytic complement activity via classical pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():634-6. PubMed ID: 2355588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunopathologic reactions in systemic lupus erythematosus and rheumatoid arthritis].
    Tarasenko RV
    Vrach Delo; 1974 Feb; (2):24-7. PubMed ID: 4468615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.